Drug Profile

Research programme: stem cell therapeutics - BioRestorative Therapies

Alternative Names: Metabolic Program - BioRestorative Therapies; ThermoStem

Latest Information Update: 02 Jun 2025

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator BioRestorative Therapies
Class Stem cell therapies
Mechanism of Action Cell replacements

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Preclinical Diabetes mellitus; Metabolic disorders; Obesity
No development reported Cardiovascular disorders; Hypertension

Most Recent Events

31 Mar 2025 The European Patent Office issues a Notice of Allowance for a new patent application (European Patent Appl. No. 207 981 30.9) covering key aspects of BioRestorative’s allogeneic, off-the-shelf ThermoStem® metabolic disease platform
28 Feb 2025 No recent reports of development identified for preclinical development in Diabetes-mellitus in USA (Injection, Implant)
28 Feb 2025 No recent reports of development identified for preclinical development in Metabolic-disorders in USA (Injection, Implant)

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com